Prognostic Indicators Involved In NK T Cell Lymphoma

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer) cells of the immune system. They are:

This subtype of lymphoma most often occurs in the nose or nasopharynx, and presents first as a nasal obstruction and/or nasal discharge.

Prognostic Indicators

Certain specific factors have been found to serve as fairly reliable prognostic indicators of extranodal NK T cell lymphoma. They are:

  • Stage at diagnosis (the lower the better)
  • Age (under age 60 = better prognosis)
  • Absence or presence of B symptoms (the absence of B symptoms suggests a better prognosis)
  • Performance status (i.e. how affected is the patient by the disease? The less affected, the better the prognosis).

Ultimately, NK T cell lymphoma has very poor survival rates and general prognoses. For instance, overall survival of patients with extranodal NK T cell lymphoma is 30-40%, meaning that 3 or 4 of every ten patients with this disease is expected to be alive five years from diagnosis. The news is much worse for aggressive NK cell leukemia—most patients do not survive more than a few months after initial symptoms appear.

Treating NK T Cell Lymphoma

There is currently no clear consensus in the cancer community regarding the best and most effective first-line treatment for NK T cell lymphoma. In some cases, radiotherapy is the preferred treatment, since NK T cell lymphoma does not traditionally respond well to conventional chemotherapeutic regimens, but to this end they are the only modes of treatment that have been explored to any reasonable degree. Depending on the disease and the patient, treatment may include chemotherapy regimens such as CHOP, DA-EPOCH, or SMILE, followed by radiation.

Sources

  • Wong KF. NK cell neoplasias. Atlas Genet Cytogenet Oncol Haematol.
  • National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Non-Hodgkin's Lymphomas, V.I.

Photo: Pexels

More Articles

More Articles

Lymphoma patients may have the option to participate in clinical trials, gaining access to an experimental treatment before it is widely available...

Since there are several subtypes of T cell lymphoma, there will necessarily be several non-specific T cell lymphoma...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

After surviving lymphoma treatments, patients should be on the lookout for late effects. These are symptoms that arise well after treatment has...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

The short answer: both. Let's begin with a simple definition of radiation: Radiation is the energy emitted from an energy source. That energy...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...